Interacting Drugs |
Physostigmine vs Corticosteroids (Systemic) |
Security Level |
 |
Mechanism |
Corticosteroids (Systemic): May enhance the adverse/toxic effect of Acetylcholinesterase Inhibitors. Increased muscular weakness may occur. |
Management |
Monitor therapy |
Physostigmine vs Corticosteroids (Systemic)
Post Review about Physostigmine vs Corticosteroids (Systemic) Click here to cancel reply.
Other Interactions of Physostigmine
Other Interactions of Corticosteroids (Systemic)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.